Effect of thyme Spray on oropharyngeal bacterial colonization

Effect of thyme spray on oropharyngeal bacterial colonization in patients hospitalized in critical care units

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180623040212N1

Enrollment

Registered

2019-07-21

Start date

2018-07-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal bacterial colonization. Acute pharyngitis, unspecified

Interventions

Intervention 1: The first intervention group, in addition to routine oral care, which consists of 0.2% chlorhexidine mouth washing, manufactured by Behsa Pharmaceutical Company (Iran), three times a d

Eligibility

Sex/Gender

All

Age

15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Hospitalization time is less than 24 hours. Patients' age between 15 to 75 years. The patient's level of consciousness is between 3-15 according to Glasgow's coma scale. The patient feed via nasogastric tube.

Exclusion criteria

Exclusion criteria: Immunodeficiency due to chemotherapy, radiotherapy and immunosuppressive diseases. Confirmed hypersensitivity to thyme compounds.

Design outcomes

Primary

Measure	Time frame
Oropharyngeal Bacterial colonization. Timepoint: Admission time at critical care unit (before intervention) and 48 hours later. Method of measurement: Evaluation of the number of bacterial colonies in the pharynx culture sample.;Beck Oral Assessment. Timepoint: Admission time at critical care unit (before intervention) and 48 hours later. Method of measurement: Beck Oral Assessment Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Soleimani

Semnan University of Medical Sciences

soli257@yahoo.com+98 23 3365 4190

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026